Adage Capital Partners Gp, L.L.C. Edgewise Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 240,000 shares of EWTX stock, worth $5.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
240,000
Previous 21,509
1015.81%
Holding current value
$5.61 Million
Previous $574,000
1016.38%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$351 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$208 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$144 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$141 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$117 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.48B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...